Current therapy of pulmonary and disseminated fungal diseases

Chest. 1983 Jun;83(6):911-7. doi: 10.1378/chest.83.6.911.
No abstract available

Publication types

  • Review

MeSH terms

  • Amphotericin B / adverse effects
  • Amphotericin B / metabolism
  • Amphotericin B / therapeutic use
  • Antifungal Agents / adverse effects
  • Antifungal Agents / metabolism
  • Antifungal Agents / therapeutic use*
  • Aspergillosis / drug therapy
  • Blastomycosis / drug therapy
  • Candidiasis / drug therapy
  • Chromoblastomycosis / drug therapy
  • Coccidioidomycosis / drug therapy
  • Cryptococcosis / drug therapy
  • Flucytosine / metabolism
  • Flucytosine / therapeutic use
  • Histoplasmosis / drug therapy
  • Humans
  • Imidazoles / adverse effects
  • Imidazoles / metabolism
  • Imidazoles / therapeutic use
  • Ketoconazole
  • Lung Diseases, Fungal / drug therapy*
  • Miconazole / metabolism
  • Miconazole / therapeutic use
  • Mycoses / drug therapy*
  • Nausea / chemically induced
  • Piperazines / adverse effects
  • Piperazines / metabolism
  • Piperazines / therapeutic use
  • Vomiting / chemically induced

Substances

  • Antifungal Agents
  • Imidazoles
  • Piperazines
  • Miconazole
  • Amphotericin B
  • Flucytosine
  • Ketoconazole